Beta Bionics (NASDAQ:BBNX) Coverage Initiated at Leerink Partners
Equities researchers at Leerink Partners assumed coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a research report issued on Monday, Marketbeat reports. The brokerage set an “outperform” rating and a $28.00 price target on the stock. Leerink Partners’ target price suggests a potential upside of 46.06% from the company’s previous close. […]
Equities researchers at Leerink Partners assumed coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a research report issued on Monday, Marketbeat reports. The brokerage set an “outperform” rating and a $28.00 price target on the stock. Leerink Partners’ target price suggests a potential upside of 46.06% from the company’s previous close. […]
